Axogen Inc (NAS:AXGN)
$ 13.99 -0.42 (-2.91%) Market Cap: 634.16 Mil Enterprise Value: 678.49 Mil PE Ratio: 0 PB Ratio: 6.38 GF Score: 78/100

AxoGen Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 12:30PM GMT
Release Date Price: $9.38 (+4.57%)
Mike Sarcone
Jefferies LLC - Analyst

You can kick this off. Good morning, everyone, and welcome to day one of the Jefferies 2023 Healthcare Conference. My name is Mike Sarcone. I'm an analyst on the medical supplies and devices team.

And we're happy to kick off the med devices track today with Axogen. They're a leader in peripheral nerve repair. And from the company, we've got Karen Zaderej, Chairwoman, CEO, and President; and Pete Mariani, CFO. Karen and Pete, thanks for joining us today.

Karen Zaderej
Axogen, Inc. - Chairman, CEO & President

Thank you, Mike.

Pete Mariani
Axogen, Inc. - EVP & CFO

Thanks.

Questions & Answers

Mike Sarcone
Jefferies LLC - Analyst

Great. So I guess just to kick off, just talking about recent performance, Axogen has posted mid to high teens growth in the last three quarters. And that includes 18% growth in 1Q. You maintained your 11% to 15% top-line sales growth guidance for 2023.

I guess, can you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot